Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Bassam Basulaiman"'
Autor:
Mark Clemons, Dean Fergusson, Anil A. Joy, Kednapa Thavorn, Judith Meza-Junco, Julie Price Hiller, John Mackey, Terry Ng, Xiaofu Zhu, Mohammed F.K. Ibrahim, Marta Sienkiewicz, Deanna Saunders, Lisa Vandermeer, Gregory Pond, Bassam Basulaiman, Arif Awan, Lacey Pitre, Nancy A. Nixon, Brian Hutton, John F. Hilton
Publikováno v:
Breast, Vol 58, Iss , Pp 42-49 (2021)
Background: Primary febrile neutropenia (FN) prophylaxis with ciprofloxacin or granulocyte-colony stimulating factors (G-CSF) is recommended with docetaxel-cyclophosphamide (TC) chemotherapy for early-stage breast cancer (EBC). A pragmatic randomised
Externí odkaz:
https://doaj.org/article/7167d8bf23184b0bbe70775be20aa64b
Autor:
Arif Awan, Bassam Basulaiman, Carol Stober, Mark Clemons, Dean Fergusson, John Hilton, Waleed Al Ghareeb, Rachel Goodwin, Mohammed Ibrahim, Brian Hutton, Lisa Vandermeer, Ranjeeta Mallick, Michael M. Vickers
Publikováno v:
Health Science Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Background and Aims Optimal management of cancer treatment‐induced hypomagnesemia (hMg) is not known. We assessed the feasibility of using a novel pragmatic clinical trials model to compare two commonly used oral Mg replacement strategies.
Externí odkaz:
https://doaj.org/article/e7ab467f882149c78edb5d5ab9e43411
Observational study and literature review of the use of camel urine for treatment of cancer patients
Autor:
Ali Al Zahrani, Ali Alfakeeh, Waleed Alghareeb, Hatoon Bakhribah, Bassam Basulaiman, Abdullah Alsuhail, Abdullah Alsharm
Publikováno v:
Eastern Mediterranean Health Journal.
Background: Complementary and alternative medicine is widely used in Saudi Arabia. One of the commonly used methods is camel urine alone or mixed with camel milk, which is supported by vague religious beliefs. Aims: To observe and follow up our cance
Autor:
Julie A. Price Hiller, Nancy A. Nixon, Anil A. Joy, Bassam Basulaiman, John Hilton, Terry L. Ng, Mohammed F.K. Ibrahim, Dean Fergusson, Marta Sienkiewicz, Arif Awan, Brian Hutton, Mark Clemons, Lisa Vandermeer, John R. Mackey, Deanna Saunders, Xiaofu Zhu, Gregory R. Pond, Judith Meza-Junco, Lacey D. Pitre, Kednapa Thavorn
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 58, Iss, Pp 42-49 (2021)
Breast, Vol 58, Iss, Pp 42-49 (2021)
Background Primary febrile neutropenia (FN) prophylaxis with ciprofloxacin or granulocyte-colony stimulating factors (G-CSF) is recommended with docetaxel-cyclophosphamide (TC) chemotherapy for early-stage breast cancer (EBC). A pragmatic randomised
Autor:
Lisa Vandermeer, Mark Clemons, Bassam Basulaiman, Labib Zibdawi, Terry L. Ng, Eitan Amir, Dean Fergusson, Deanna Saunders, Demetrios Simos, Arif Awan, Marta Sienkiewicz, Brian Hutton
Publikováno v:
Supportive Care in Cancer. 29:5787-5795
Taxane-associated pain syndrome (TAPS) is common with docetaxel and is characterised by myalgias and arthralgias starting 2–3 days after treatment and can last for up to 7 days. Anecdotal evidence suggests that corticosteroids can reduce TAPS. This
Autor:
Mohammad Jaffal, Anas Alghamdi, Faris Hamadi, Faez Albabakri, Abdulrahman Albaradie, Bassam Basulaiman, Ruqayya Azher, Redhwan Alshabi, Waleed Alghareeb, Emad Tashkandi
Publikováno v:
Cancer Management and Research. 12:12301-12308
Purpose Despite advancements in cancer therapeutics, mortality and morbidity due to anti-cancer treatments still occur but are not frequently reported. We aimed to report the 30-day mortality and morbidity of all curative and palliative anti-cancer t
Autor:
Arif Awan, Marta Sienkiewicz, Amirrtha Srikanthan, Terry L. Ng, Deanna Saunders, Bassam Basulaiman, Megan M. Tu, Ricardo Fernandes, Mohammed F. K. Ibrahim, Lisa Vandermeer, Sharon F. McGee, Ahwon Jeong, Mark Clemons, Carol Stober, Brian Hutton
Publikováno v:
Supportive Care in Cancer. 29:925-943
Bone-modifying agents (BMAs) for bone metastases are commonly prescribed for many years even though randomized clinical trials are only 1–2 years in duration. A systematic review on the risk-benefit of BMA use for > 2 years in breast cancer or cast
Autor:
Arif Awan, Bassam Basulaiman, Mark Clemons, Debbie Bedard, Carol Stober, Andrew Robinson, Anne Kehoe, Deanna Saunders, Marie-Claude Brunet, Dean Fergusson, Ranjeeta Mallick, Brian Hutton, Sasha Mazzarello, Lisa Vandermeer, Fiona MacDonald
Publikováno v:
Supportive Care in Cancer. 28:4891-4899
Trastuzumab-based chemotherapy is usually administered through either a peripherally inserted central catheter (PICC) or a totally implanted vascular access device (PORT). As the most effective type of access is unknown, a feasibility trial, prior to
Autor:
Francesco Gabriele Tatangelo Fazzari, Garth Nicholas, Bassam Basulaiman, Kim Bourgeau, Foster Rose, Brian Hutton, Mohammed F. K. Ibrahim, Evelyne Guay, Mehrnoosh Pauls, Terry L. Ng, Tu Megan
Publikováno v:
Critical reviews in oncology/hematology. 169
Aim Conduct a systematic review of the effectiveness of systemic therapies for adult recurrent glioblastoma (rGBM). Methods We electronically searched for randomized controlled trials from three major databases and four conferences from 2009-Dec 2020
Autor:
Kednapa Thavorn, Anil Abraham Joy, Mark Clemons, Carol Stober, Arif Awan, Bassam Basulaiman, Angel Arnaout, Brian Hutton, Nadia Califaretti, John Hilton, Dean Fergusson, Andrew Robinson, Marta Sienkiewicz, Lisa Vandermeer
Publikováno v:
Breast Cancer Research and Treatment. 177:93-101
The proportion of breast cancer patients enrolled in clinical trials is falling. The Rethinking Clinical Trials (REaCT) program was developed to challenge some of the contemporary barriers responsible for this fall in accrual. In this article, we rev